1. Home
  2. BGMS vs EVGN Comparison

BGMS vs EVGN Comparison

Compare BGMS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio Green Med Solution Inc.

BGMS

Bio Green Med Solution Inc.

HOLD

Current Price

$0.92

Market Cap

5.9M

Sector

N/A

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.54

Market Cap

5.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGMS
EVGN
Founded
1996
1999
Country
Malaysia
Israel
Employees
19
N/A
Industry
Agricultural Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BGMS
EVGN
Price
$0.92
$0.54
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
106.7K
862.8K
Earning Date
05-08-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$80,482.35
$73.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.37
52 Week High
$6.70
$1.50

Technical Indicators

Market Signals
Indicator
BGMS
EVGN
Relative Strength Index (RSI) 52.05 50.73
Support Level $0.89 $0.52
Resistance Level $1.13 $0.68
Average True Range (ATR) 0.08 0.06
MACD 0.00 0.01
Stochastic Oscillator 49.21 46.27

Price Performance

Historical Comparison
BGMS
EVGN

About BGMS Bio Green Med Solution Inc.

Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: